Despite SC intensifying its focus on misleading ads, amendment to curb fake ads by drug cos delayed since 2020
Supreme Court addresses misleading ads, pending amendments to DMR(OA) Act since Feb 2020 with Union health ministry. Proposed changes aim to enhance penalties for prohibited drug ads. Complaints against Patanjali under DMRA.